Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2003 Sep 20;327(7416):681-2; author reply 682.
doi: 10.1136/bmj.327.7416.681-c.

Conundrum of the HOPE study: time of taking ramipril may account for lack of relation between blood pressure and outcome

Comment

Conundrum of the HOPE study: time of taking ramipril may account for lack of relation between blood pressure and outcome

Roy Taylor. BMJ. .
No abstract available

PubMed Disclaimer

Comment in

Comment on

  • Use of ramipril in preventing stroke: double blind randomised trial.
    Bosch J, Yusuf S, Pogue J, Sleight P, Lonn E, Rangoonwala B, Davies R, Ostergren J, Probstfield J; HOPE Investigators. Heart outcomes prevention evaluation. Bosch J, et al. BMJ. 2002 Mar 23;324(7339):699-702. doi: 10.1136/bmj.324.7339.699. BMJ. 2002. PMID: 11909785 Free PMC article. Clinical Trial.

References

    1. HOPE Investigators. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342: 145-53. - PubMed
    1. Sleight P, Yusuf S, Pogue J, Psuyuki R, Probstfield J. Blood pressure reduction and cardiovascular risk in HOPE study. Lancet 2001;358: 2130-1. - PubMed
    1. Bosch J, Yusuf S, Pogue J, Sleight P, Lonn E, Rangoonwala B, et al. Effect of ramipril in preventing stroke: double blind randomised trial. BMJ 2002;324: 699-702. - PMC - PubMed
    1. Svensson P, de Faire U, Sleight P, Yusuf S, Ostergren J. Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE substudy. Hypertension 2001;38: e28-32. - PubMed
    1. Sleight P, Pogue J, Yusef S. Blood pressure and cardiovascular risk in the HOPE study. Author's reply. Lancet 2002;359: 2118. - PubMed

MeSH terms